Literature DB >> 21152698

Liver regeneration associated protein (ALR) exhibits antimetastatic potential in hepatocellular carcinoma.

Rania Dayoub1, Hannah Wagner, Frauke Bataille, Oliver Stöltzing, Thilo Spruss, Christa Buechler, Hans-Jürgen Schlitt, Thomas S Weiss.   

Abstract

Augmenter of liver regeneration (ALR), which is critically important in liver regeneration and hepatocyte proliferation, is highly expressed in cirrhotic livers and hepatocellular carcinomas (HCC). In the current study, the functional role of ALR in hepatocancerogenesis was analyzed in more detail. HepG2 cells, in which the cytosolic 15 kDa ALR isoform was reexpressed stably, (HepG2-ALR) were used in migration and invasion assays using modified Boyden chambers. Epithelial-mesenchymal transition (EMT) markers were determined in HepG2-ALR cells in vitro and in HepG2-ALR tumors grown in nude mice. ALR protein was quantified in HCC and nontumorous tissues by immunohistochemistry. HepG2-ALR, compared with HepG2 cells, demonstrated reduced cell motility and increased expression of the epithelial cell markers E-cadherin and Zona occludens-1 (ZO-1), whereas SNAIL, a negative regulator of E-cadherin, was diminished. Matrix metalloproteinase MMP1 and MMP3 mRNA expression and activity were reduced. HepG2-ALR cell-derived subcutaneously grown tumors displayed fewer necrotic areas, more epithelial-like cell growth and fewer polymorphisms and atypical mitotic figures than tumors derived from HepG2 cells. Analysis of tumor tissues of 53 patients with HCC demonstrated an inverse correlation of ALR protein with histological angioinvasion and grading. The 15 kDa ALR isoform was found mainly in HCC tissues without histological angioinvasion 0. In summary the present data indicate that cytosolic ALR reduces hepatoma cell migration, augments epithelial growth and, therefore, may act as an antimetastatic and EMT reversing protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21152698      PMCID: PMC3060984          DOI: 10.2119/molmed.2010.00117

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  41 in total

Review 1.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

2.  Reactive oxygen species mediated sustained activation of protein kinase C alpha and extracellular signal-regulated kinase for migration of human hepatoma cell Hepg2.

Authors:  Wen-Sheng Wu; Rong Kung Tsai; Chung Hsing Chang; Sindy Wang; Jia-Ru Wu; Yu-Xun Chang
Journal:  Mol Cancer Res       Date:  2006-10       Impact factor: 5.852

3.  Complete pathway for protein disulfide bond formation encoded by poxviruses.

Authors:  Tatiana G Senkevich; Christine L White; Eugene V Koonin; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

4.  An essential function of the mitochondrial sulfhydryl oxidase Erv1p/ALR in the maturation of cytosolic Fe/S proteins.

Authors:  H Lange; T Lisowsky; J Gerber; U Mühlenhoff; G Kispal; R Lill
Journal:  EMBO Rep       Date:  2001-08       Impact factor: 8.807

5.  Stimulation of the mitogen-activated protein kinase cascade and tyrosine phosphorylation of the epidermal growth factor receptor by hepatopoietin.

Authors:  Y Li; M Li; G Xing; Z Hu; Q Wang; C Dong; H Wei; G Fan; J Chen; X Yang; S Zhao; H Chen; K Guan; C Wu; C Zhang; F He
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

6.  Direct association of hepatopoietin with thioredoxin constitutes a redox signal transduction in activation of AP-1/NF-kappaB.

Authors:  Yingxian Li; Wanying Liu; Guichun Xing; Chunyan Tian; Yunping Zhu; Fuchu He
Journal:  Cell Signal       Date:  2004-12-25       Impact factor: 4.315

7.  A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation.

Authors:  T G Senkevich; C L White; E V Koonin; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

8.  Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes.

Authors:  Chinnasamy Thirunavukkarasu; Lian Fu Wang; Stephen A K Harvey; Simon C Watkins; J Richard Chaillet; John Prelich; Thomas E Starzl; Chandrashekhar R Gandhi
Journal:  J Hepatol       Date:  2008-01-28       Impact factor: 25.083

9.  Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.

Authors:  Yingxian Li; Chengrong Lu; Guichun Xing; Yunping Zhu; Fuchu He
Journal:  Exp Cell Res       Date:  2004-11-01       Impact factor: 3.905

10.  Hepatic stimulator substance administration ameliorates liver regeneration in an animal model of fulminant hepatic failure and encephalopathy.

Authors:  Alexandra P Margeli; Lila Papadimitriou; Sotirios Ninos; Evangelos Manolis; Michael G Mykoniatis; Stamatios E Theocharis
Journal:  Liver Int       Date:  2003-06       Impact factor: 5.828

View more
  12 in total

1.  Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma.

Authors:  Yuan-Yuan Guo; Yuan Wu; Xiao-Wei Jia; Wei An
Journal:  Lab Invest       Date:  2017-08-21       Impact factor: 5.662

2.  Nrf2 activates augmenter of liver regeneration (ALR) via antioxidant response element and links oxidative stress to liver regeneration.

Authors:  Rania Dayoub; Arndt Vogel; Jutta Schuett; Madeleine Lupke; Susannah M Spieker; Nadja Kettern; Eberhard Hildt; Michael Melter; Thomas S Weiss
Journal:  Mol Med       Date:  2013-08-28       Impact factor: 6.354

3.  Newly established human liver cell line: a potential cell source for the bioartificial liver in the future.

Authors:  Hongling Liu; Shaoli You; Yihui Rong; Yichen Wu; Bing Zhu; Zhihong Wan; Wanshu Liu; Panyong Mao; Shaojie Xin
Journal:  Hum Cell       Date:  2013-12       Impact factor: 4.174

4.  Augmenter of liver regeneration (ALR) is a novel biomarker of hepatocellular stress/inflammation: in vitro, in vivo and in silico studies.

Authors:  Yoram Vodovotz; John Prelich; Claudio Lagoa; Derek Barclay; Ruben Zamora; Noriko Murase; Chandrashekhar R Gandhi
Journal:  Mol Med       Date:  2013-01-22       Impact factor: 6.354

5.  Adenoviral gene transfer of hepatic stimulator substance confers resistance against hepatic ischemia-reperfusion injury by improving mitochondrial function.

Authors:  Shu-Jun Jiang; Wen Li; Wei An
Journal:  Hum Gene Ther       Date:  2013-04       Impact factor: 5.695

6.  Involvement of hepatic stimulator substance in the regulation of hepatoblast maturation into hepatocytes in vitro.

Authors:  Guang-Yong Sun; Ling-Yue Dong; Wei An
Journal:  Stem Cells Dev       Date:  2014-05-02       Impact factor: 3.272

7.  The Level of ALR is Regulated by the Quantity of Mitochondrial DNA.

Authors:  Tibor Balogh; Tamás Lőrincz; Ibolya Stiller; József Mandl; Gábor Bánhegyi; András Szarka
Journal:  Pathol Oncol Res       Date:  2015-11-19       Impact factor: 3.201

8.  Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.

Authors:  Thomas S Weiss; Madeleine Lupke; Sara Ibrahim; Christa Buechler; Julia Lorenz; Petra Ruemmele; Ute Hofmann; Michael Melter; Rania Dayoub
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

9.  Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis.

Authors:  Yiwei Dong; Qianqian Cai; Lisheng Fu; Haojie Liu; Mingzhe Ma; Xingzhong Wu
Journal:  Biomed Res Int       Date:  2021-07-19       Impact factor: 3.411

10.  High expression of 23 kDa protein of augmenter of liver regeneration (ALR) in human hepatocellular carcinoma.

Authors:  Hai-Ying Yu; Man-Hua Zhu; Dai-Rong Xiang; Jun Li; Ji-Fang Sheng
Journal:  Onco Targets Ther       Date:  2014-06-02       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.